---
title: "CQP: The repurchase has not yet been implemented"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251613366.md"
description: "CQP announced that as of July 31, 2025, the company has not yet implemented this repurchase. The company plans to use its own funds and a special loan for stock repurchase to repurchase the issued ordinary shares of RMB through the centralized bidding trading method in the Shenzhen Stock Exchange trading system, aimed at reducing the company's registered capital. The total amount of funds used for the repurchase of shares will not be less than RMB 80 million and not exceed RMB 100 million, with a repurchase price not exceeding RMB 6.6 per share, and the repurchase period will be within 12 months from the date of the shareholders' meeting approving the repurchase of shares"
datetime: "2025-08-05T10:21:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251613366.md)
  - [en](https://longbridge.com/en/news/251613366.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251613366.md)
---

# CQP: The repurchase has not yet been implemented

CQP announced that as of July 31, 2025, the company has not yet implemented this repurchase. The company plans to use its own funds and a special loan for stock repurchase to buy back its issued ordinary shares of RMB through the centralized bidding trading method on the Shenzhen Stock Exchange, aimed at reducing the company's registered capital. The total amount of funds for the repurchase will not be less than RMB 80 million and not exceed RMB 100 million, with a repurchase price not exceeding RMB 6.6 per share, and the repurchase period will be within 12 months from the date the shareholders' meeting approves the repurchase of shares

### Related Stocks

- [000950.CN](https://longbridge.com/en/quote/000950.CN.md)

## Related News & Research

- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)